Zentalis Pharmaceuticals, Inc.
ZNTL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001725160
In the last 90 days, Zentalis Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 114 institutions reported holding it in 13F filings for Q2 2026, worth $228.9M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Zentalis Pharmaceuticals, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 114
- +14 vs. Q1 2026
- Shares held
- 47.4M
- +4.10M (+9.5%) vs. Q1 2026
- Total value
- $228.9M
- +$127.9M (+126.6%) vs. Q1 2026
- New holders
- 33
- 29 more added
- Sold out
- 19
- 32 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZNTL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 114 | $228.9M |
| Q1 2026 | 102 | $101.7M |
| Q4 2025 | 86 | $54.9M |
| Q3 2025 | 99 | $79.7M |
| Q2 2025 | 117 | $64.5M |
| Q1 2025 | 132 | $92.9M |
| Q4 2024 | 142 | $195.2M |
| Q3 2024 | 136 | $261.2M |
| Q2 2024 | 145 | $314.3M |
| Q1 2024 | 142 | $1.34B |
| Q4 2023 | 120 | $1.23B |
| Q3 2023 | 137 | $1.61B |
| Q2 2023 | 134 | $2.32B |
| Q1 2023 | 110 | $1.15B |
| Q4 2022 | 106 | $1.30B |
| Q3 2022 | 121 | $1.27B |
| Q2 2022 | 122 | $1.64B |
| Q1 2022 | 128 | $2.05B |
| Q4 2021 | 139 | $3.61B |
| Q3 2021 | 116 | $2.75B |
| Q2 2021 | 120 | $2.13B |
| Q1 2021 | 95 | $1.58B |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Zentalis Pharmaceuticals, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ishara Investments LP | 1,025,000 | $4.97M | 3.72% | −205,000−16.7% | Reduced |
| Bank of America Corp | 1,114,650 | $5.41M | 0.00% | −17,644−1.6% | Reduced |
| Geode Capital Management, LLC | 1,284,117 | $6.23M | 0.00% | +663,081+106.8% | Added |
| Decheng Capital LLC | 1,323,327 | $6.42M | 0.88% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 1,390,576 | $6.74M | 0.13% | +1,390,576 | New |
| Opaleye Management Inc. | 1,412,656 | $6.85M | 0.62% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 1,609,078 | $7.80M | 0.01% | −329,067−17.0% | Reduced |
| Citadel Advisors LLC | 2,298,403 | $11.1M | 0.01% | +566,320+32.7% | Added |
| Acadian Asset Management LLC | 2,681,900 | $13.0M | 0.02% | −166,352−5.8% | Reduced |
| Vanguard Capital Management LLC | 2,835,669 | $13.8M | 0.00% | +524,962+22.7% | Added |
| Two Sigma Investments, LP | 3,024,936 | $14.7M | 0.01% | +68,410+2.3% | Added |
| Squadron Capital Management LLC | 3,700,000 | $17.9M | 6.14% | +69,000+1.9% | Added |
| BlackRock, Inc. | 3,753,525 | $18.2M | 0.00% | +2,483,688+195.6% | Added |
| 5AM Venture Management, LLC | 3,947,913 | $19.1M | 6.65% | 00.0% | Unchanged |
| Almitas Capital LLC | 0 | $0 | 0.00% | −610,073−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −266,032−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −139,690−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −117,127−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −94,854−100.0% | Sold out |
| 49 Wealth Management, LLC | 0 | $0 | 0.00% | −66,401−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −52,185−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −47,700−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −47,063−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −34,849−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −29,899−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −22,675−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −20,850−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −20,600−100.0% | Sold out |
| Birchview Capital, LP | 0 | $0 | 0.00% | −17,503−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −16,700−100.0% | Sold out |
| CTC Alternative Strategies, Ltd. | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −10,662−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1,460−100.0% | Sold out |
| Anfield Capital Management, LLC | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |